These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 3009142)

  • 21. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
    Gehlert DR; Schober DA; Beavers L; Gadski R; Hoffman JA; Smiley DL; Chance RE; Lundell I; Larhammar D
    Mol Pharmacol; 1996 Jul; 50(1):112-8. PubMed ID: 8700103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
    Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
    J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of selective, high affinity [125I]-angiotensin and [125I]-bradykinin binding sites in rat intestinal epithelia.
    Cox HM; Munday KA; Poat JA
    Br J Pharmacol; 1986 Jan; 87(1):201-9. PubMed ID: 2869810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of specific binding sites for vasoactive intestinal peptide in rat intestinal epithelial cell membranes.
    Amiranoff B; Laburthe M; Rosselin G
    Biochim Biophys Acta; 1980 Jan; 627(2):215-24. PubMed ID: 7350925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain peptide YY receptors: highly conserved characteristics throughout vertebrate evolution.
    Okita M; Inui A; Hirosue Y; Miura M; Nakajima M; Kasuga M
    Endocrinology; 1991 Nov; 129(5):2512-20. PubMed ID: 1657579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and molecular characterization of the isoquinoline rat intestinal binding site using 6,7-dimethoxy-4-(4'-amino-3'-[125I]iodobenzyl) isoquinoline.
    Servin AL; Christinaki H; Viel C
    Mol Pharmacol; 1986 Oct; 30(4):379-87. PubMed ID: 3762524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide YY receptor in submucosal and myenteric plexus synaptosomes of canine small intestine.
    Mao YK; Wang YF; Ward G; Cipris S; Daniel EE; McDonald TJ
    Am J Physiol; 1996 Jul; 271(1 Pt 1):G36-41. PubMed ID: 8760104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of 125I-neuropeptide Y with rat cardiac membranes.
    Sheriff S; Rigel DF; Fischer JE; Balasubramaniam A
    Neuropeptides; 1990 Mar; 15(3):157-60. PubMed ID: 2174520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological profile of the rat intestinal crypt peptide YY receptor vs. the recombinant rat Y5 receptor.
    Goumain M; Voisin T; Lorinet AM; Balasubramaniam A; Laburthe M
    Eur J Pharmacol; 1998 Dec; 362(2-3):245-9. PubMed ID: 9874177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation and characterization of binding sites for islet amyloid polypeptide in rat membranes.
    Bhogal R; Smith DM; Bloom SR
    Endocrinology; 1992 Feb; 130(2):906-13. PubMed ID: 1310282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.
    Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R
    Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple affinity forms of the calcitonin gene-related peptide receptor in rat cerebellum.
    Chatterjee TK; Fisher RA
    Mol Pharmacol; 1991 Jun; 39(6):798-804. PubMed ID: 1646951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropeptide Y modulates the binding of a gonadotropin-releasing hormone (GnRH) analog to anterior pituitary GnRH receptor sites.
    Parker SL; Kalra SP; Crowley WR
    Endocrinology; 1991 May; 128(5):2309-16. PubMed ID: 1850349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of axonally transported [125I]PYY binding sites in rat vagus nerve.
    Corp ES; Smith GP
    Brain Res; 1991 Jul; 553(1):175-9. PubMed ID: 1718539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural characterization of Y1 and Y2 receptors for neuropeptide Y and peptide YY by affinity cross-linking.
    Sheikh SP; Williams JA
    J Biol Chem; 1990 May; 265(14):8304-10. PubMed ID: 2159475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solubilization of high affinity corticotropin-releasing factor receptors from rat brain: characterization of an active digitonin-solubilized receptor complex.
    Grigoriadis DE; Zaczek R; Pearsall DM; De Souza EB
    Endocrinology; 1989 Dec; 125(6):3068-77. PubMed ID: 2555137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization of Y1 receptors for NPY and PYY on vascular smooth muscle cells in rat pancreas.
    Sheikh SP; Roach E; Fuhlendorff J; Williams JA
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G250-7. PubMed ID: 1847590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of vasoactive intestinal peptide receptors in human colonic epithelial cells.
    Broyart JP; Dupont C; Laburthe M; Rosselin G
    J Clin Endocrinol Metab; 1981 Apr; 52(4):715-21. PubMed ID: 6259191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for further heterogeneity of the receptors for neuropeptide-Y and peptide-YY in tumor cell lines derived from neural crest.
    Inui A; Sano K; Miura M; Hirosue Y; Nakajima M; Okita M; Baba S; Kasuga M
    Endocrinology; 1992 Nov; 131(5):2090-6. PubMed ID: 1330489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.